Press Releases
Glioblastoma Multiforme (GBM) Market Size, Share & Trend | Industry Analysis Report, 2026

, 22 September 2018 -- A key factor contributing to growth of the glioblastoma multiforme market is the rising number of brain and other nervous system cancers occurring worldwide.

Glioblastoma Multiforme (GBM), also known as glioblastoma, is a form of brain cancer. It is a rapidly-growing glioma that develops from star-shaped glial cells, such as oligodendrocytes and astrocytes that support the nerve cells in the brain. GBM is also called as grade IV astrocytoma and is among the most invasive forms of glial tumors. It is a fast-growing and aggressive form of tumor in the central nervous system (CNS) and generally spreads to the nearby brain tissues. Its symptoms include seizures, constant headaches, vomiting, blurred or double vision, and difficulty in speaking.
Read Report Overview:
A key factor contributing to growth of the glioblastoma multiforme market is the rising number of brain and other nervous system cancers occurring worldwide. Globally, GBM accounted for 54% of new gliomas and 45% of primary malignant tumors. According to the U.S National Cancer Institute 2015 estimates 22,850 ###### comprising 10,280 women and 12,630 men were diagnosed with brain and other forms of nervous system cancer. The rising number of cases of GBM is expected to drive the glioblastoma multiforme market during the forecast period. Increase in funding for companies involved in the research on GBM is also contributing to the growth of the glioblastoma multiforme market. For instance, in February 2018, Novocure announced that it would receive fresh infusion of capital from BioPharma Credit PLC, which is an investment fund of Pharmakon Advisors, LP.
The term loan agreement for US$ 150 Mn will be used by Novocure to accelerate its R&D on improved treatment option for GBM. Additionally, companies are focusing on the development of new drugs and therapies in order to maintain their competitive advantage and penetrate new regional markets. In December 2017, Genentech, a subsidiary of Roche, announced that it had received approval from U.S. Food and Drug Administration (FDA) for Avastin (bevacizumab) to be used in the treatment glioblastoma in ######. In September 2017, the FDA approved Amgen’s MVASI (bevacizumab-awwb), which is the first bevacizumab biosimilar as well as the first anti-cancer biosimilar to be approved for the treatment of five types of cancer, including GBM. In July 2016, Mylan launched Temozolomide capsules, the generic version of Merck’s Temodar, in the U.S. The capsules are indicated for use concomitantly with radiotherapy in ##### patients for the treatment of glioblastoma multiforme.
Request Brochure of Report:
The glioblastoma multiforme market can be segmented based on treatment type, end-user, and geography. In terms of treatment type, the market can be divided into drugs, electric-field therapy, and others. The drugs segment can be further divided into antineoplastic agents, anticonvulsants, and corticosteroids. Based on end-user, the glioblastoma multiforme market can be classified into hospitals, ambulatory surgical centers, and specialty clinics.
Geographically, the global glioblastoma multiforme market can be segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global glioblastoma multiforme market due to rise in funding for research & development of novel drugs and therapies for the treatment of glioblastoma. North America is followed by Europe and Asia Pacific. Grant of regulatory approval for new treatment therapies for glioblastoma is propelling the growth of the glioblastoma multiforme market in Asia Pacific. In December 2017, the Ministry of Health, Labour and Welfare in Japan approved the recommendation of the Central Social Insurance Medical Council (Chuikyo) for providing reimbursement for Novocure’s Optune, which is a non-invasive, portable device used in the treatment of newly diagnosed glioblastoma.
Request For TOC :
Prominent players operating in the global glioblastoma multiforme market are Bexion Pharmaceuticals, LLC, Bristol-Myers Squibb, Double Bond Pharmaceutical, Diffusion Pharmaceuticals, F. Hoffmann-La Roche AG., GW Pharmaceuticals, plc. Merck & Co., Inc., MimiVax, LLC, Novocure, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453

# # #

Submitted by Sandy Researcher, Transparency Market Research on Saturday, 22 September 2018 at 4:44 PM
Category: Health Care & Medical
Related News

Professional Survey Report On Global Dental Restorative Materials Market | ResearchMoz
Wednesday, 12 Dec 2018

Global Diagnostic Reagents Market | Top Leading Vendors Such As Roche, Abbott
Wednesday, 12 Dec 2018

Global Clinical Data Analytics Market Research Analyst Focuses on Companies like Athenahealth
Wednesday, 12 Dec 2018

ResearchMoz: Growing Demand For Global Circulating Tumor Cell Market Size, Status and Forecast 2018
Wednesday, 12 Dec 2018

Global Bionic Exoskeletons Market Forecast By Top Leading Manufacturers | Ekso Bionics, Ottobock Inc
Wednesday, 12 Dec 2018

Related Events

5th Winter Process Chemistry Conference And Exhibition, Manchester, UK
Tuesday, 11 Dec 2018

The 38th Annual Meeting of the Israeli Orthopaedic Association, Tel-Aviv
Wednesday, 12 Dec 2018

3rd New Product Planning Summit
Wednesday, 12 Dec 2018

Tumor Targeted Lymphocyte Summit 2018 | Boston, MA | December 12-13, 2018
Wednesday, 12 Dec 2018

Advances in Inflammatory Bowel Diseases (AIBD) December 13-15, 2018
Thursday, 13 Dec 2018

Latest News

The Low-down on the Child and Dependent Care Credit 2018, 2019
Thursday, 13 Dec 2018

Control Valves Market Latest Trends, Growth, Opportunities And Forecasts by 2023
Thursday, 13 Dec 2018

Tungsten Carbide Powder Market Growth, Demand, Size, Analysis And Forecast By 2023
Thursday, 13 Dec 2018

Thursday, 13 Dec 2018

Thursday, 13 Dec 2018

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Thursday, 13 December 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: Cyber Tuesday - Cyber Range Level 1
  • 5th Winter Process Chemistry Conference And Exhibition, Manchester, UK
  • Palo Alto Networks: Ultimate Test Drive - Threat Prevention
  • Palo Alto Networks: Get Hands-on with the VM-Series on Microsoft Azure
  • IEE International Conference on the Science of Electrical Engineering

  • Latest Jobs
    Sorry, there are currently no entries posted here.